Infrared imaging of meibomian glands and evaluation of the lipid layer in Sjögren’s syndrome patients and nondry eye controls

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 2, 2015, Pages 836-841

  Menzies, Kara L ^a   Srinivasan, Sruthi ^a   Prokopich, C Lisa ^a   Jones, Lyndon ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Dry eye; Lipid layer; Meibography; MGD; Sj gren s syndrome; Tear breakup time

Indexed keywords

ARTIFICIAL TEAR; AUTOANTIGEN; CYCLOSPORIN; OMEGA 3 FATTY ACID; LIPID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DRY EYE; FEMALE; HUMAN; LIPID LAYER THICKNESS; MALE; MEIBOMIAN GLAND; MEIBOMIAN GLAND EXPRESSIBILITY AND SECRETION QUALITY; NEAR INFRARED IMAGING SYSTEM; NONINVASIVE TEAR BREAKUP TIME; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SJOEGREN SYNDROME; STAINING; VISUAL ACUITY TESTING EQUIPMENT; VISUAL SYSTEM PARAMETERS; CHEMISTRY; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; INFRARED RADIATION; LACRIMAL FLUID; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SECRETION (PROCESS); SJOGREN'S SYNDROME;

DIAGNOSTIC IMAGING; FEMALE; HUMANS; INFRARED RAYS; LIPIDS; MALE; MEIBOMIAN GLANDS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SJOGREN'S SYNDROME; TEARS;

EID: 84922370890     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-13864     Document Type: Article

References (48)

1. Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S. The complexity of Sjogren’s syndrome: novel aspects on pathogenesis. Immunol Lett. 2011;141:1-9.
2. Tabbara KF, Vera-Cristo CL. Sjogren syndrome. Curr Opin Ophthalmol. 2000;11:449-454.
3. Caffery B, Simpson T, Wang S, et al. Factor analysis of the clinical characteristics of primary Sjögren syndrome. Optom Vis Sci. 2010;87:742-750.
4. Nikolov NP, Illei GG. Pathogenesis of Sjögren’s syndrome. Curr Opin Rheumatol. 2009;21:465-470.
5. Bjerrum K, Prause JU. Primary Sjögren’s syndrome: a subjective description of the disease. Clin Exp Rheumatol. 1990;8:283-288.
6. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554-558.
7. Goransson LG, Haldorsen K, Brun JG, et al. The point prevalence of clinically relevant primary Sjögren’s syndrome in two Norwegian counties. Scand J Rheumatol. 2011;40: 221-224.
8. Zhang NZ, Shi CS, Yao QP, et al. Prevalence of primary Sjögren’s syndrome in China. J Rheumatol. 1995;22:659-661.
9. Bowman SJ, Ibrahim GH, Holmes G, Hamburger J, Ainsworth JR. Estimating the prevalence among Caucasian women of primary Sjögren’s syndrome in two general practices in Birmingham, UK. Scand J Rheumatol. 2004;33:39-43.
10. Fox RI. Sjögren’s syndrome. Lancet. 2005;366:321-331.
11. Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arth Care Res. 2012;64:475-487.
12. Lemp MA, Foulks GN. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocular Surf. 2007;5:75-92.
13. Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K. Meibomian gland dysfunction in patients with Sjögren’s syndrome. Ophthalmology. 1998;105:1485-1488.
14. Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci. 2011;52:1938-1978.
15. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52:1930-1937.
16. Krenzer KL, Dana MR, Ullman MD, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab. 2000;85:4874-4882.
17. Arita R, Itoh K, Inoue K, Kuchiba A, Yamaguchi T, Amano S. Contact lens wear is associated with decrease of meibomian glands. Ophthalmology. 2009;116:379-384.
18. Borchman D, Foulks GN, Yappert MC, et al. Physical changes in human meibum with age as measured by infrared spectroscopy. Ophthalmic Res. 2010;44:34-42.
19. Den S, Shimizu K, Ikeda T, Tsubota K, Shimmura S, Shimazaki J. Association between meibomian gland changes and aging, sex, or tear function. Cornea. 2006;25:651-655.
20. Srinivasan S, Menzies K, Sorbara L, Jones L. Infrared imaging of meibomian gland structure using a novel keratograph. Optom Vis Sci. 2012;89:788-794.
21. Srinivasan S, Menzies KL, Sorbara L, Jones L, Sickenberger W. Meibography of the upper lid. Optician. 2011;242:12-13.
22. Miller KL, Walt JG, Mink DR, et al. Minimal clinically important difference for Ocular Surf disease index. Arch Ophthalmol. 2010;128:94-101.
23. Srinivasan S, Joyce E, Boone A, Simpson T, Jones L, Senchyna M. Tear lipocalin and lysozyme concentrations in postmenopausal women. Ophthalmic Phys Optics. 2010;30:257-266
24. van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969;82:10-14.
25. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640-650.
26. Whitcher JP, Shiboski CH, Shiboski SC, et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren’s Syndrome International Registry. Am J Ophthalmol. 2010;149(3:405-415).
27. Guillon JP. Noninvasive Tearscope Plus routine for contact lens fitting. Cont Lens Anterior Eye. 1998;21(suppl 1):S31-S40.
28. Guillon M, Styles E, Guillon JP, Maissa C. Preocular tear film characteristics of nonwearers and soft contact lens wearers. Optom Vis Sci. 1997;74:273-279.
29. Maissa C, Guillon M. Tear film dynamics and lipid layer characteristics-effect of age and gender. Cont Lens Anterior Eye. 2010;33:176-182.
30. Guillon JP, Guillon M. The role of tears in contact lens performance and its measurement. In: Ruben M, Guillon M, eds. Contact Lens Practice. London: Chapman and Hall; 1994: 452-483.
31. Rae SM, Price HC. The effect of soft contact lens wear and time from blink on wavefront aberration measurement variation. Clin Exp Optom. 2009;92:274-282.
32. Pult H, Sickenberger W. LIPCOF and contact lens wearers: a new tool of forecast subjective dryness and degree of comfort of contact lens wearers. Contactologia. 2000;22:74-79.
33. Pult H, Murphy PJ, Purslow C. A novel method to predict the dry eye symptoms in new contact lens wearers. Optom Vis Sci. 2009;86:E1042-E1050.
34. Pult H, Purslow C, Berry M, Murphy PJ. Clinical tests for successful contact lens wear: relationship and predictive potential. Optom Vis Sci. 2008;85:E924-E929.
35. Korb DR, Blackie CA. Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location. Cornea. 2008;27:1142-1147.
36. Arita R, Itoh K, Maeda S, et al. Proposed diagnostic criteria for obstructive meibomian gland dysfunction. Ophthalmology. 2009;116:2058-2063.
37. Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology. 2008; 115:911-915.
38. Lemp MA. Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007). Ocular Surf. 2007;5:179-193.
39. Bron AJ, Tiffany JM. The contribution of meibomian disease to dry eye. Ocular Surf. 2004;2:149-165.
40. Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp Eye Res. 2004;78:347-360.
41. Goto E, Matsumoto Y, Kamoi M, et al. Tear evaporation rates in Sjögren’s syndrome and nonSjogren dry eye patients. Am J Ophthalmol. 2007;144:81-85.
42. Villani E, Beretta S, De Capitani M, Galimberti D, Viola F, Ratiglia R. In vivo confocal microscopy of meibomian glands in Sjögren’s syndrome. Invest Ophthalmol Vis Sci. 2011;52:933-939.
43. Sullivan DA, Sullivan BD, Ullman MD, et al. Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci. 2000;41:3732-3742.
44. Sullivan DA, Wickham LA, Rocha EM, et al. Androgens and dry eye in Sjögren’s syndrome. Ann N Y Acad Sci. 1999;876:312-324.
45. Sullivan DA, Belanger A, Cermak JM, et al. Are women with Sjögren’s syndrome androgen-deficient? J Rheumatol. 2003; 30:2413-2419.
46. Schirra F, Hoh H, Kienecker C, Ruprecht KW. Using LIPCOF (lid-parallel conjunctival fold) for assessing the degree of dry eye, it is essential to observe the exact position of that specific fold. Adv Exp Med Biol. 1998;438:853-858.
47. Nemeth J, Fodor E, Lang Z, et al. Lid-parallel conjunctival folds (LIPCOF) and dry eye: a multicentre study. Br J Ophthalmol. 2012;96:1380-1385.
48. Zhang X, Li Q, Zou H, et al. Assessing the severity of conjunctivochalasis in a senile population: a community-based epidemiology study in Shanghai, China. BMC Pub Health. 2011;11:198.